Covalon Technologies Ltd.

Research Covalon Technologies Ltd. (COV) on Bullrun: valuation model: 7.7% overvalued, market cap CAD 58.00M, P/E 42.0. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCOV
• ExchangeV
• CountryCanada
• SectorHealthcare
• IndustryMedical Instruments & Supplies
• CurrencyCAD
• Valuation signal7.7% overvalued
• Market capCAD 58.00M
• P/E42.0
• Financial periodQ4 2025
• RevenueCAD 6.89M
• Net incomeCAD 125.38K
• Free cash flowCAD 5.03M
• Gross margin58.2%

Valuation Snapshot

Bullrun's latest valuation model marks Covalon Technologies Ltd. as 7.7% overvalued; latest market cap is CAD 58.00M; P/E is 42.0.

About Covalon Technologies Ltd.

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle East, Canada, Latin America, Asia, and internationally.

Frequently asked questions

Is Covalon Technologies Ltd. overvalued or undervalued?

Bullrun's valuation model currently marks Covalon Technologies Ltd. as 7.7% overvalued.

What is Covalon Technologies Ltd.'s market cap?

Covalon Technologies Ltd.'s market capitalization is CAD 58.00M.

What is Covalon Technologies Ltd.'s P/E ratio?

Covalon Technologies Ltd.'s price-to-earnings (P/E) ratio is 42.0.

What does Covalon Technologies Ltd. do?

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle East, Canada, Latin America, Asia, and internationally.